Search results for: COVID-19 Research

Incentives, Competition, and Pharmaceutical Innovation in Europe: The Case of Direct Acting Antivirals for Hepatitis C

26 July 2018

…data exclusivity (DE), and Supplementary Protection Certificates (SPCs), is seen as important. This is due to the high cost of research and development (R&D) for new medicines and the issue…

Around The World in HTAs: Thailand – An Ever-Evolving Policy Tool

9 September 2024

…across UCBP, NLEM, and NLEV. Step 3 involves commissioning the assessments to research teams and evaluating the evidence. Researchers must follow the methods guidelines when conducting cost-effectiveness and budget impact analyses,…

Giving Priority to the Severely Ill: Social Preferences and Value Based Assessment

30 January 2014, 12:00am

…a more detailed system of burden of illness weights derived from the results of research by Dr Rowen and her colleagues. The presentation summarised the research and considered how the…

Generating Preference-based Values for the EQ-5D-Y to Support Its Use in HTA

31 January 2019

…N., Herdman, M., Jelsma J., Kind, P., Scalone, L. and Ravens-Sieberer, U., 2010. Development of the EQ-5D-Y: A child-friendly version of the EQ-5D. Quality of Life Research, 19(6), pp.875-886. DOI….

OHE at ISPOR Europe 2018

Meet some of the OHE team at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Europe 2018 conference in Barcelona, 10-14 November. Meet some of the OHE team at…

OHE Seminar: Patents, Price Controls, and the Global Diffusion of New Drugs

5 June 2016, 11:00pm

…Research Associate in the Productivity, Innovation and Entrepreneurship Program of the National Bureau of Economic Research in Cambridge, Massachusetts.  He has a PhD in Economics from Harvard University, and is…

OHE Lunchtime Seminar: Health Technology Assessment Scientific and Outcomes Advice on Medicinal Drug Development

4 October 2016, 11:00pm

…include three presenters, all of whom are involved in issues directly relevant to HTA SA: Dr Leeza Osipenko, Head of Scientific Advice, NICE Professor Nancy Devlin, Director of Research, OHE…

OHE’s 2016 Annual Lecture with Dame Sally Davies: 10 Years of NIHR: Achievements and Challenges for the Next Decade

7 November 2016, 12:00am

…Davies on Monday 7 November 2016 at the Royal College of Physicians, London. Professor Davies will use the occasion of the 10th Anniversary of the National Institute for Health Research…

OHE Lunchtime Seminar: Management in the NHS

4 September 2017, 11:00pm

…and Imperial College Business School, London, where she is also currently the Associate Dean for Faculty and Research. Her research interests focus on the impact of incentives on the quality…